Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Pilot Study of EUS-Guided Radiofrequency and FOLFIRINOX in Advanced Pancreatic Cancer (RadioFAP ) [NA]
A clinical trial update describes a pilot study combining EUS-guided radiofrequency ablation with FOLFIRINOX for advanced pancreatic cancer,…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma
An ongoing clinical trial sponsored by Carol Davila University of Medicine and Pharmacy is assessing the prevalence of pancreatic steatosis …
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency [Phase 2]
Phase 2 trial evaluating Pancreaze (pancrelipase) in patients with pancreatic adenocarcinoma and exocrine pancreatic insufficiency; results …
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
This is a clinical trial update describing the LINFU U.S. Registry for patients with intraductal papillary mucinous neoplasm (IPMN) of the p…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer [Phase 1]
Phase 1 study evaluating adding BAY 1895344 to standard chemotherapy for advanced solid tumors, focusing on small cell lung cancer, poorly d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Study of LP-184 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Lantern Pharma's LP-184 is being studied in a phase 1/2 trial for advanced and metastatic solid tumors, with indications including glioblast…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma [Phase 1]
Phase 1b study of CCX872-B in pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Personalized Vaccine with SOC Chemo Followed by Nivo in Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating a personalized vaccine in combination with standard-of-care chemotherapy followed by nivolumab in pancreatic adenoc…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial [Phase 2]
A randomized phase II trial evaluating perioperative NALIRIFOX (liposomal irinotecan in combination with fluorouracil, leucovorin, and oxali…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating carbon ion radiotherapy for resectable or borderline resectable pancreatic cancer has been terminated.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC [Phase 2]
Phase 2 trial evaluating QL1706 with AG chemotherapy as first-line treatment for advanced pancreatic adenocarcinoma. The study is not yet re…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.
This clinical trial update describes the PARA study on risk factors for exocrine pancreatic neoplasms, focusing on pancreatic adenocarcinoma…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. [Phase 1, Phase 2]
Clinical trial update indicating an early-phase study of XNW27011 for multiple advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma
This clinical trial update from Charles University investigates whether secretin-stimulated pancreatic secretion affects ctDNA expression in…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Namodenoson Treatment of Advanced Pancreatic Cancer [Phase 2]
Clinical trial update for Namodenoson in advanced pancreatic cancer (pancreatic adenocarcinoma). The Phase 2 study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial update investigating first-line treatment of advanced pancreatic cancer with albumin-bound paclitaxel and gemcitabine, with or…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial update evaluating mFOLFIRINOX with or without stereotactic body radiotherapy for locally advanced, non-resectable p…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating disulfiram in combination with chemotherapy for patients with refractory solid tumors or metastatic pancreatic canc…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer [Phase 3]
A Phase 3 clinical trial comparing glufosfamide to 5-fluorouracil in patients with second-line metastatic pancreatic adenocarcinoma is curre…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Evaluation of Polychemotherapy With XELOXIRI-3 in Elderly or Frail Patients With Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating XELOXIRI-3 in elderly or frail patients with advanced pancreatic adenocarcinoma has been terminated.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC [Phase 3]
Phase 3 clinical trial comparing standard versus prolonged neoadjuvant chemotherapy before surgery for locally advanced or borderline resect…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)
NORPACT-2 is a neoadjuvant chemotherapy trial for locally advanced and borderline resectable pancreatic adenocarcinoma, sponsored by Oslo Un…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of an immunostimulatory oncolytic adenovirus has completed with posted results across pancreatic adenocarcinoma, ovarian c…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 trial of ganitumab in locally advanced unresectable pancreatic cancer has been terminated; results were posted on 2024-11-08.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery [Phase 3]
Phase 3 trial updates evaluate gemcitabine with or without erlotinib followed by the same regimen with or without radiation therapy and cape…